Drug Trials Snapshots: REZZAYO is an echinocandin antifungal that is indicated in patients 18 years of age or older who have limited or no alternative options for the treatment of candidemia and invasive candidiasis (IC).
fda.gov
fda.gov
RSS Hunter
2026-04-29